Literature DB >> 7724707

Effects of indorenate on food intake: a comparison with fenfluramine and amphetamine.

D N Velázquez Martínez1, M Valencia Flores, M López Cabrera, J E Villarreal.   

Abstract

Indorenate (TR3369, 5-methoxytryptamine b-methylcarboxylate HCl) is a 5-HT1-like receptor agonist with hypotensive activity. Here, we describe that indorenate also decreases food intake (ED50 26.1 mg/kg) without an appreciable effect in water intake (the estimated ED50 for water was 589.8 mg/kg). The anorectic activity of indorenate was compared to the effects of amphetamine and other serotonin agonists; the effect of indorenate was smaller than those of the other compounds; however, the effect of indorenate was specific to food, whereas all the other drugs also produced significant decrements in water intake. The serotonin antagonists cinanserin, cyproheptadine, methergoline and methysergide effectively prevented the decrease in food intake produced by indorenate and fenfluramine. Haloperidol, a dopaminergic antagonist, was ineffective in preventing the effect of indorenate although it prevented the anorectic effect of amphetamine. The present results suggest the participation of serotoninergic, but not dopaminergic mechanisms, in the decrease in food intake produced by indorenate.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7724707     DOI: 10.1007/bf02245103

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  44 in total

Review 1.  Pharmacological approaches to appetite suppression.

Authors:  J Blundell
Journal:  Trends Pharmacol Sci       Date:  1991-04       Impact factor: 14.819

2.  Evidence for the involvement of the 5-HT1A receptor in the anxiolytic action of indorenate and ipsapirone.

Authors:  A Fernández-Guasti; C López-Rubalcava
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  Role of brain monoamines in the anorectic activity of mazindol and d-amphetamine in the rat.

Authors:  R Samanin; C Bendotti; S Bernasconi; E Borroni; S Garattini
Journal:  Eur J Pharmacol       Date:  1977-05-15       Impact factor: 4.432

4.  Inhibition of drug-induced anorexia in rats by methysergide.

Authors:  A M Barrett; L McSharry
Journal:  J Pharm Pharmacol       Date:  1975-12       Impact factor: 3.765

5.  External carotid vasodilation induced by serotonin and indorenate.

Authors:  E Hong; C M Villalon
Journal:  Proc West Pharmacol Soc       Date:  1988

6.  Comparative study of the anorectic activity of phenindamine d-amphetamine and fenfluramine in different species.

Authors:  A Abdallah; H D White
Journal:  Arch Int Pharmacodyn Ther       Date:  1970-12

7.  Anorexigenic and ancillary actions of MK-212 (6-chloro-2-(1-piperazinyl)-pyrazine; CPP).

Authors:  B V Clineschmidt; H M Hanson; A B Pflueger; J C McGuffin
Journal:  Psychopharmacology (Berl)       Date:  1977-11-24       Impact factor: 4.530

8.  3H-TVX Q 7821: identification of 5-HT1 binding sites as target for a novel putative anxiolytic.

Authors:  W U Dompert; T Glaser; J Traber
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-02       Impact factor: 3.000

9.  Behavioural actions of the serotonergic anxiolytic indorenate.

Authors:  A Fernández-Guasti; A Escalante; E Hong; A Agmo
Journal:  Pharmacol Biochem Behav       Date:  1990-09       Impact factor: 3.533

10.  Chlorophenylpiperazine: a central serotonin agonist causing powerful anorexia in rats.

Authors:  R Samanin; T Mennini; A Ferraris; C Bendotti; F Borsini; S Garattini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-08       Impact factor: 3.000

View more
  4 in total

Review 1.  Pharmacological approaches for the treatment of obesity.

Authors:  José-Antonio Fernández-López; Xavier Remesar; Màrius Foz; Marià Alemany
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Evidence for the sensitivity of operant timing behaviour to stimulation of D1 dopamine receptors.

Authors:  T H C Cheung; G Bezzina; C L Hampson; S Body; K C F Fone; C M Bradshaw; E Szabadi
Journal:  Psychopharmacology (Berl)       Date:  2007-08-01       Impact factor: 4.530

3.  Evidence for a role of D1 dopamine receptors in d-amphetamine's effect on timing behaviour in the free-operant psychophysical procedure.

Authors:  T H C Cheung; G Bezzina; K Asgari; S Body; K C F Fone; C M Bradshaw; E Szabadi
Journal:  Psychopharmacology (Berl)       Date:  2006-03-15       Impact factor: 4.530

4.  Haloperidol and clozapine antagonise amphetamine-induced disruption of latent inhibition of conditioned taste aversion.

Authors:  Holger Russig; Aneta Kovacevic; Carol A Murphy; Joram Feldon
Journal:  Psychopharmacology (Berl)       Date:  2003-07-25       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.